These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29494731)

  • 1. Detecting Chemotherapeutic Skin Adverse Reactions in Social Health Networks Using Deep Learning.
    Ransohoff JD; Nikfarjam A; Jones E; Loew B; Kwong BY; Sarin KY; Shah NH
    JAMA Oncol; 2018 Apr; 4(4):581-583. PubMed ID: 29494731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?
    Michel C; Scosyrev E; Petrin M; Schmouder R
    Clin Drug Investig; 2017 May; 37(5):415-422. PubMed ID: 28224371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015.
    Dodiuk-Gad RP; Olteanu C; Chung WH; Shear NH
    Drug Saf; 2016 Mar; 39(3):271-6. PubMed ID: 26798049
    [No Abstract]   [Full Text] [Related]  

  • 4. The class imbalance problem detecting adverse drug reactions in electronic health records.
    Santiso S; Casillas A; Pérez A
    Health Informatics J; 2019 Dec; 25(4):1768-1778. PubMed ID: 30230408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electronic Health Data for Postmarket Surveillance: A Vision Not Realized.
    Moore TJ; Furberg CD
    Drug Saf; 2015 Jul; 38(7):601-10. PubMed ID: 26025018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on: "Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts".
    Magge A; Sarker A; Nikfarjam A; Gonzalez-Hernandez G
    J Am Med Inform Assoc; 2019 Jun; 26(6):577-579. PubMed ID: 31087070
    [No Abstract]   [Full Text] [Related]  

  • 7. A method for systematic discovery of adverse drug events from clinical notes.
    Wang G; Jung K; Winnenburg R; Shah NH
    J Am Med Inform Assoc; 2015 Nov; 22(6):1196-204. PubMed ID: 26232442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of adverse drug reactions: evaluation of an automatic data processing applied in oncology performed in the French Diagnosis Related Groups database.
    Quillet A; Colin O; Bourgeois N; Favrelière S; Ferru A; Boinot L; Lafay-Chebassier C; Perault-Pochat MC
    Fundam Clin Pharmacol; 2018 Apr; 32(2):227-233. PubMed ID: 29143369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting software failures in the MAUDE database: a preliminary analysis.
    Pecoraro F; Luzi D
    Stud Health Technol Inform; 2013; 192():1098. PubMed ID: 23920872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric post-marketing safety systems in North America: assessment of the current status.
    McMahon AW; Wharton GT; Bonnel R; DeCelle M; Swank K; Testoni D; Cope JU; Smith PB; Wu E; Murphy MD
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):785-92. PubMed ID: 26098297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common Models, Different Approaches.
    Gagne JJ
    Drug Saf; 2015 Aug; 38(8):683-6. PubMed ID: 26088718
    [No Abstract]   [Full Text] [Related]  

  • 12. Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS.
    Colilla S; Tov EY; Zhang L; Kurzinger ML; Tcherny-Lessenot S; Penfornis C; Jen S; Gonzalez DS; Caubel P; Welsh S; Juhaeri J
    Drug Saf; 2017 May; 40(5):399-408. PubMed ID: 28155198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug makers' adverse event reports are often incomplete, US report finds.
    McCarthy M
    BMJ; 2015 Feb; 350():h651. PubMed ID: 25652561
    [No Abstract]   [Full Text] [Related]  

  • 14. Recognising severe cutaneous adverse drug reactions.
    Chee P
    Med J Aust; 2017 Oct; 207(8):325-327. PubMed ID: 29020897
    [No Abstract]   [Full Text] [Related]  

  • 15. Mucocutaneous reactions to chemotherapy.
    Susser WS; Whitaker-Worth DL; Grant-Kels JM
    J Am Acad Dermatol; 1999 Mar; 40(3):367-98; quiz 399-400. PubMed ID: 10071309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When More Is Less: An Exploratory Study of the Precautionary Reporting Bias and Its Impact on Safety Signal Detection.
    Klein K; Scholl JHG; De Bruin ML; van Puijenbroek EP; Leufkens HGM; Stolk P
    Clin Pharmacol Ther; 2018 Feb; 103(2):296-303. PubMed ID: 28913827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SSEL-ADE: A semi-supervised ensemble learning framework for extracting adverse drug events from social media.
    Liu J; Zhao S; Wang G
    Artif Intell Med; 2018 Jan; 84():34-49. PubMed ID: 29111222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging Contextual Information in Extracting Long Distance Relations from Clinical Notes.
    Guan H; Devarakonda M
    AMIA Annu Symp Proc; 2019; 2019():1051-1060. PubMed ID: 32308902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacovigilance: Importance, concepts, and processes.
    Kumar A
    Am J Health Syst Pharm; 2017 Apr; 74(8):606-612. PubMed ID: 28235869
    [No Abstract]   [Full Text] [Related]  

  • 20. Empowering consumers as contributors for health product safety: lessons from the Philippines.
    Hartigan-Go K
    Drug Saf; 2015 Apr; 38(4):329-35. PubMed ID: 25698347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.